ALZN
Alzamend NeuroยทNASDAQ
--
--(--)
--
--(--)
ALZN Profile
Alzamend Neuro, Inc.
An early clinical-stage biopharmaceutical company that developing novel products for the Alzheimer's disease, bipolar disorder, major depressive disorder and post-traumatic stress disorder
3480 Peachtree Road NE, Second Floor Suite 103, Atlanta, GA 30326
--
Alzamend Neuro, Inc., was incorporated in Delaware on February 26, 2016. The company is a clinical-stage biopharmaceutical company focused on developing new products for the treatment of Alzheimer's disease, bipolar disorder, major depression and post-traumatic stress disorder. The company has launched two product candidates with the goal of bringing treatments not only for Alzheimer's disease, but also bipolar disorder, major depression and post-traumatic stress disorder. The company has developed a new way to fight Alzheimer's through immunotherapy.
